The invention relates to the cycloalkyl methoxybenzyl phenyl pyran derivatives as Sodium dependent glucose co transporter (SGLT) inhibitors, particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 with them, and processes for preparing them.
这项发明涉及环烷基
甲氧基苯基
吡喃衍
生物作为
钠依赖型
葡萄糖共转运蛋白(SGLT)
抑制剂,特别是SGLT2,以及使用它们治疗受
SGLT2抑制的疾病、症状和/或疾病的方法,以及它们的制备过程。